Senior insider sale
EVP & CFO at ROYALTY PHARMA PLC — senior position signals high conviction
$4.12M
75.40K shares
What this filing means
COYNE TERRANCE P. plans to sell 75.40K shares of ROYALTY PHARMA PLC valued at approximately $4.12M. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 8/13/2026ACC: 0001958244-26-000508
Officer· EVP & CFO
Since Jun 2020
75.40K
Shares to sell
$4.12M
Approx. market value
11K
Acquired (3 months)
1
Planned
1 completed
Securities Acquired — Last 3 Months1
Acquired as compensation -- Performance Awards
Compensation
8/5/2026
11KTotal acquired11K
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
8/5/2026 | Acquired as compensation -- Performance Awards Compensation | 11K | — |
| Total | 11K | ||
Planned & Completed Dispositions2
Completed
—Completed
Units to sell
64.40K
Market value
$3.48M
5/26/2026
Planned — Approximate Date
NASDPlanned
Units to sell
11K
Market value
$644.3K
8/13/2026
Total
Units
75.40K
Value
$4.12M
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
| Completed | ||||
5/26/2026 | 64.40K | $3.48M | — | Completed |
| Planned — Approximate Date | ||||
8/13/2026 | 11K | $644.3K | NASD | Planned |
| Total | 75.40K | $4.12M | ||